Cardiome Pharma Corp (NASDAQ:CRME)

CAPS Rating: 1 out of 5

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

CRME News and Commentary

Caps

How do you think CRME will perform against the market?

Add Stock to CAPS Watchlist

All Players

179 Outperform
26 Underperform
 

All-Star Players

33 Outperform
14 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top CRME Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Hotpicks101 (28.91)
Submitted December 14, 2010

Just following some other highly ranked players. Didn't do any other due diligence.

zzlangerhans (99.83)
Submitted April 14, 2013

Cardiome should be given credit for wriggling out of their heavy debt to Merck by paying only 40% of what they owed, but now they have to face a very uncertain future with only 28M in cash and a single asset that no one seems to want. When I saw that… More

CRME VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CRME.

Recs

2
Member Avatar zzlangerhans (99.83) Submitted: 4/14/2013 2:17:34 AM : Underperform Start Price: $1.99 CRME Score: +78.06

Cardiome should be given credit for wriggling out of their heavy debt to Merck by paying only 40% of what they owed, but now they have to face a very uncertain future with only 28M in cash and a single asset that no one seems to want. When I saw that tiny Cardiome was planning to hire their own reps to push Brinavess in Europe I shuddered. If Merck couldn't move a vial of the stuff in two years, is Cardiome really going to change how European cardiologists do their business? Meanwhile, further development of IV vernakalant in the US and oral vernakalant remain in limbo and I think it's unlikely Cardiome will be able to attract a new dance partner.

Recs

0
Member Avatar Lcrazylegs84 (< 20) Submitted: 9/17/2011 6:33:57 PM : Outperform Start Price: $18.30 CRME Score: -205.19

going going up

Recs

0
Member Avatar bearsniper (< 20) Submitted: 5/13/2011 12:40:46 AM : Outperform Start Price: $24.45 CRME Score: -181.58

Multiple products in the pipe line. Has real potential to be bought out by a major drug company.

Leaderboard

Find the members with the highest scoring picks in CRME.

Score Leader

anticitradeshort

anticitradeshort (30.14) Score: +294.52

The Score Leader is the player with the highest score across all their picks in CRME.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 30.14 4/20/2009 Underperform NS $20.75 -92.00% +202.52% +294.52 0 Comment
chefheitman 94.19 10/1/2009 Underperform 5Y $21.35 -92.22% +147.15% +239.38 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $19.65 -91.55% +145.95% +237.50 0 Comment
PurePwnage 98.96 11/27/2009 Underperform 5Y $19.40 -91.44% +136.26% +227.71 0 Comment
DiamondDawg 93.33 11/25/2009 Underperform 5Y $19.95 -91.68% +130.38% +222.06 0 Comment
shorttest4 41.79 3/8/2010 Underperform 5Y $27.70 -94.01% +124.15% +218.15 0 Comment
haimp 24.44 10/7/2010 Underperform 5Y $29.13 -94.30% +121.01% +215.31 0 Comment
raaziq 85.01 7/15/2008 Underperform NS $51.25 -96.76% +116.98% +213.74 0 Comment
schwah5 93.79 7/30/2008 Underperform NS $56.35 -97.05% +108.02% +205.08 0 Comment
CrazyCal17 81.90 8/20/2008 Underperform 5Y $43.05 -96.14% +107.06% +203.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRBCCapMkts 88.34 4/27/2011 Outperform NS $23.45 -81.06% +3.78% -84.84 3/20/2012 @ $4.44 0 Comment
TrackJGreenblatt 67.03 2/28/2011 Outperform 1Y $28.75 -61.57% +2.17% -63.74 2/23/2012 @ $11.05 1 Comment
TrackWedbush 86.95 12/8/2010 Outperform NS $29.45 -94.36% +108.25% -202.62 0 Comment
TrackUBS 93.61 6/23/2010 Outperform NS $39.80 -95.83% +134.83% -230.66 0 Comment
TrackOppenheimer 66.78 12/1/2008 Outperform NS $21.75 -92.37% +200.27% -292.64 0 Comment
TrackLeerinkSwan 97.28 11/17/2008 Outperform NS $19.80 -91.62% +200.97% -292.59 0 Comment
TrackWellsFargo 90.18 3/20/2008 Outperform NS $40.50 -95.90% +104.23% -200.13 0 Comment
TrackBearStearns < 20 2/23/2007 Outperform NS $57.50 -95.00% -5.26% -89.74 4/17/2012 @ $2.88 0 Comment

Featured Broker Partners